Magellan Healthcare Launches New Digital Emotional Wellbeing Program
28 Dicembre 2021 - 12:30PM
Business Wire
Program builds on NeuroFlow’s Behavioral Health
Platform for Members
Magellan Healthcare, one of the nation’s leaders in behavioral
health and a division of Magellan Health, Inc. (NASDAQ: MGLN), will
soon launch a new Digital Emotional Wellbeing program that helps
members improve overall health and wellbeing, manage stress and
build resilience in a confidential manner.
Beginning January 1, 2022, participating Magellan members with
emotional concerns who use the NeuroFlow app or website will
receive recommendations. They will also have access to activities
to help them improve their overall health. Activities include
evidence-based videos, articles and behavioral trackers, as well as
Magellan’s digital cognitive behavioral therapy programs (DCBTs),
FearFighter® for anxiety and MoodCalmer® for depression. These
activities will provide members with personalized, self-directed
behavioral health resources, tools and support, all from the
secure, anonymous convenience of NeuroFlow’s app and website.
The Digital Emotional Wellbeing program now combines Magellan’s
evidence-based resources and clinical support with NeuroFlow's
cloud-based platform and proven engagement approach. According to
NeuroFlow data, 80% of individuals complete an initial assessment,
61% continue to use the program during the first month, and 78% of
users have reported symptom reduction. Meanwhile, Magellan's
offerings have driven similarly impressive results, with 57% of
users reporting reduced fear and panic, and 80% reporting improved
sleep.
“Magellan Healthcare has offered DCBTs recognized by the
Substance Abuse and Mental Health Services Administration (SAMHSA)
for many years. This collaboration with NeuroFlow enables us to
offer members a seamless wellbeing solution,” said Jeff
Bringardner, senior vice president and general manager, commercial
behavioral health, Magellan Healthcare. “We are excited to put our
clinical expertise in the palms of our members’ hands and meet them
where they are in their healthcare journey.”
“The possibility of a lifetime of improved mental health
awareness can start with a single assessment, and we’re proud to
collaborate with Magellan on a solution that empowers users to take
an active role in their wellness,” said Chris Molaro, chief
executive officer, NeuroFlow. “This new program enables a
measurement-based approach to care and provides the right and
relevant resources and content based on individual
experiences.”
About Magellan Healthcare: Magellan Healthcare, Inc., the
healthcare business unit of Magellan Health, Inc., offers solutions
for complex conditions in the areas of behavioral health and
medical specialty treatment. Magellan Healthcare serves commercial
health plans, employers, state and local governments, and the
Federal government, including the Department of Defense. For more
information, visit MagellanHealthcare.com.
About Magellan Health: Magellan Health, Inc. is a leader
in managing the fastest growing, most complex areas of health,
including special populations, complete pharmacy benefits and other
specialty areas of healthcare. Magellan supports innovative ways of
accessing better health through technology, while remaining focused
on the critical personal relationships that are necessary to
achieve a healthy, vibrant life. Magellan's customers include
health plans and other managed care organizations, employers, labor
unions, various military and governmental agencies and third-party
administrators. For more information, visit MagellanHealth.com.
About NeuroFlow: NeuroFlow provides best-in-class
technology and care services for the effective integration of
behavioral health. NeuroFlow’s HIPAA-compliant platform supports
over 14 million users across 150 health systems, payors, and
organizations, helping them capture behavioral health insights and
take action to proactively manage individuals and populations
holistically. Visit neuroflow.com for more information.
(MGLN-GEN)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211228005046/en/
Media Contact: Lilly Ackley, ackleyl@magellanhealth.com,
(860) 507-1923 Investor Contact: Darren Lehrich,
lehrichd@magellanhealth.com, (917) 291-9311
Grafico Azioni Magellan Health (NASDAQ:MGLN)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Magellan Health (NASDAQ:MGLN)
Storico
Da Giu 2023 a Giu 2024